Fine-Mapping of IL16 Gene and Prostate Cancer Risk in African Americans

Background: Prostate cancer is the most common type of cancer among men in the United States, and its incidence and mortality rates are disproportionate among ethnic groups. Although genome-wide association studies of European descents have identified candidate loci associated with prostate cancer risk, including a variant in IL16, replication studies in African Americans (AA) have been inconsistent. Here we explore single-nucleotide polymorphism (SNP) variation in IL16 in AAs and test for association with prostate cancer. Methods: Association tests were conducted for 2,257 genotyped and imputed SNPs spanning IL16 in 605 AA prostate cancer cases and controls from Washington, D.C. Eleven of them were also genotyped in a replication population of 1,093 AAs from Chicago. We tested for allelic association adjusting for age, global and local West African ancestry. Results: Analyses of genotyped and imputed SNPs revealed that a cluster of IL16 SNPs were significantly associated with prostate cancer risk. The strongest association was found at rs7175701 (P = 9.8 × 10−8). In the Chicago population, another SNP (rs11556218) was associated with prostate cancer risk (P = 0.01). In the pooled analysis, we identified three independent loci within IL16 that were associated with prostate cancer risk. SNP expression quantitative trait loci analyses revealed that rs7175701 is predicted to influence the expression of IL16 and other cancer-related genes. Conclusion: Our study provides evidence that IL16 polymorphisms play a role in prostate cancer susceptibility among AAs. Impact: Our findings are significant given that there has been limited focus on the role of IL16 genetic polymorphisms on prostate cancer risk in AAs. Cancer Epidemiol Biomarkers Prev; 21(11); 2059–68. ©2012 AACR.

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  R. Kittles,et al.  Predictors of Serum Vitamin D Levels in African American and European American Men in Chicago , 2012, American journal of men's health.

[3]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[4]  Suzanne Chambers,et al.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study , 2011, Nature Genetics.

[5]  R. Millikan,et al.  Replication of GWAS “Hits” by Race for Breast and Prostate Cancers in European Americans and African Americans , 2011, Front. Gene..

[6]  C. Bunker,et al.  Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry , 2011, The Prostate.

[7]  J. Carpten,et al.  EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men , 2011, PloS one.

[8]  Gary K. Chen,et al.  Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans , 2011, PLoS genetics.

[9]  Gary K. Chen,et al.  Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21 , 2011, Nature Genetics.

[10]  Christopher Phillips,et al.  ENGINES: exploring single nucleotide variation in entire human genomes , 2011, BMC Bioinformatics.

[11]  J. Stanford,et al.  Genome-wide Association Study Identifies a Genetic Variant Associated with Risk for More Aggressive Prostate Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[12]  R. Hayes,et al.  Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence , 2011, Clinical Cancer Research.

[13]  R. Kittles,et al.  Prostate Cancer Susceptibility Loci Identified on Chromosome 12 in African Americans , 2011, PloS one.

[14]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[15]  J. Witte,et al.  Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[16]  G. Cancel-Tassin,et al.  Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy , 2010, The Prostate.

[17]  J. Marchini,et al.  Genotype imputation for genome-wide association studies , 2010, Nature Reviews Genetics.

[18]  N. Cox,et al.  Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.

[19]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[20]  J. Carpten,et al.  Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans , 2010, The Prostate.

[21]  D. Kwiatkowski,et al.  Methodological challenges of genome-wide association analysis in Africa , 2010, Nature Reviews Genetics.

[22]  Wei Zhang,et al.  SCAN: SNP and copy number annotation , 2010, Bioinform..

[23]  C. Rotimi,et al.  Transferability and Fine-Mapping of Genome-Wide Associated Loci for Adult Height across Human Populations , 2009, PloS one.

[24]  Weibo Liang,et al.  Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[25]  A. Need,et al.  Next generation disparities in human genomics: concerns and remedies. , 2009, Trends in genetics : TIG.

[26]  Kari Stefansson,et al.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility , 2009, Nature Genetics.

[27]  A. Bergh,et al.  Morphological transition of proliferative inflammatory atrophy to high‐grade intraepithelial neoplasia and cancer in human prostate , 2009, The Prostate.

[28]  A. Kibel,et al.  Prostate Cancer Risk Associated Loci in African Americans , 2009, Cancer Epidemiology Biomarkers & Prevention.

[29]  C. Rotimi,et al.  Genetic Variants Associated with Complex Human Diseases Show Wide Variation across Multiple Populations , 2009, Public Health Genomics.

[30]  John P. A. Ioannidis,et al.  Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.

[31]  Colleen D. McCabe,et al.  Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. , 2009, Cancer research.

[32]  Weibo Liang,et al.  The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. , 2008, Carcinogenesis.

[33]  J. Brooks.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008 .

[34]  J. K. Kundu,et al.  Inflammation: gearing the journey to cancer. , 2008, Mutation research.

[35]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[36]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[37]  R. Barale,et al.  A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. , 2008, DNA and cell biology.

[38]  L. Liang,et al.  A genome-wide association study of global gene expression , 2007, Nature Genetics.

[39]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[40]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[41]  Jianfeng Xu,et al.  Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.

[42]  K. Dietz,et al.  Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors , 2007, Archivum Immunologiae et Therapiae Experimentalis.

[43]  D. Ballinger,et al.  A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. , 2006, American journal of human genetics.

[44]  R. Sarisky,et al.  Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[45]  O. Bagasra,et al.  Zinc and Prostate Cancer: A Critical Scientific, Medical, and Public Interest Issue (United States) , 2005, Cancer Causes & Control.

[46]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[47]  K. Perisinakis,et al.  Serum level of interleukin‐16 in multiple myeloma patients and its relationship to disease activity , 2004, American journal of hematology.

[48]  Kazuto Ito,et al.  Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. , 2003, Cancer letters.

[49]  O. Bagasra,et al.  Prostate Cancer in African American Men Is Associated With Downregulation of Zinc Transporters , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[50]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[51]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[52]  E. Kovacs.  The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy. , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[53]  A. Sirotkin,et al.  Presumptive Mediators of Growth Hormone Action on Insulin-Like Growth Factor I Release by Porcine Ovarian Granulosa Cells , 2000, Neurosignals.

[54]  K. Asadullah,et al.  IL‐15 and IL‐16 overexpression in cutaneous T‐cell lymphomas: stage‐dependent increase in mycosis fungoides progression , 2000, Experimental dermatology.

[55]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[56]  R. Kurth,et al.  Interleukin‐16 stimulates the expression and production of pro‐inflammatory cytokines by human monocytes , 2000, Immunology.

[57]  K. Cooney,et al.  The Prostate 71 : 225 ^ 231 ( 2011 ) Evidence for anAssociationBetweenProstate Cancer andChromosome 8 q 24 and 10 q 11 GeneticVariants inAfricanAmericanMen : The FlintMen ’ sHealth Study , 2011 .

[58]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[59]  G. Kramer,et al.  The picture of the prostatic lymphokine network is becoming increasingly complex. , 2002, Reviews in urology.

[60]  Genome-wide association study identifies new prostate cancer susceptibility loci , 2022 .